International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic

Brooke L. Griffin, Jill S. Burkiewicz, Laura R. Peppers, Terri L Warholak

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose. The clinical effectiveness of a group-visit model versus individual point-of-care visits is compared by International Normalized Ratio (INR) monitoring in a pharmacist-managed anticoagulation clinic. Methods. This study was a prospective, randomized, repeated-measures, two-group, intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care ambulatory care setting. Patients were eligible for this study if they were taking warfarin therapy for at least 30 days, had a goal INR range, and provided consent. At a routine point-of-care visit, eligible patients were randomly invited to participate in group visits. The number of visits and INR values were documented prospectively for both groups during the 16-week study period. Results. Of the 45 patients who consented and enrolled in group visits, 28 patients participated for the 16-week study period. The control group included 108 patients seen by a pharmacist for individual anticoagulation appointments. No significant difference in the percentage of INR values within the therapeutic range was detected between patients in the group-visit model versus patients receiving individual visits (59% versus 56.6%, respectively; p = 0.536). Seventy-three percent of INR values for patients who attended group visits were within ±0.2 of the desired INR range compared with 71.9% of those in the control group (p = 0.994). In addition, 79% of group-visit patients were within the therapeutic range at their last clinic visit compared with 67% of patients who attended individual appointments (p = 0.225). Group visits were preferred by 51% (n = 38) of patients who completed the satisfaction survey. Of the 92 patients who declined group-visit participation, 36% indicated that the time of day that group visits were offered was inconvenient. There were no thromboembolic or hemorrhagic events documented in either group during the study period. Conclusion. Group visits in a pharmacist-managed anticoagulation clinic may provide a safe and effective alternative to individual appointments.

Original languageEnglish (US)
Pages (from-to)1218-1223
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Volume66
Issue number13
DOIs
StatePublished - Jul 1 2009

Fingerprint

International Normalized Ratio
Pharmacists
Appointments and Schedules
Point-of-Care Systems
Ambulatory Care
Control Groups
Managed Care Programs
Warfarin
Therapeutics

Keywords

  • Ambulatory care
  • Anticoagulants
  • International normalized ratio
  • Methodology
  • Patients
  • Pharmacists
  • Toxicity
  • Warfarin

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Medicine(all)

Cite this

International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic. / Griffin, Brooke L.; Burkiewicz, Jill S.; Peppers, Laura R.; Warholak, Terri L.

In: American Journal of Health-System Pharmacy, Vol. 66, No. 13, 01.07.2009, p. 1218-1223.

Research output: Contribution to journalArticle

@article{198d6f445dbc4d238efc47d6f589c97e,
title = "International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic",
abstract = "Purpose. The clinical effectiveness of a group-visit model versus individual point-of-care visits is compared by International Normalized Ratio (INR) monitoring in a pharmacist-managed anticoagulation clinic. Methods. This study was a prospective, randomized, repeated-measures, two-group, intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care ambulatory care setting. Patients were eligible for this study if they were taking warfarin therapy for at least 30 days, had a goal INR range, and provided consent. At a routine point-of-care visit, eligible patients were randomly invited to participate in group visits. The number of visits and INR values were documented prospectively for both groups during the 16-week study period. Results. Of the 45 patients who consented and enrolled in group visits, 28 patients participated for the 16-week study period. The control group included 108 patients seen by a pharmacist for individual anticoagulation appointments. No significant difference in the percentage of INR values within the therapeutic range was detected between patients in the group-visit model versus patients receiving individual visits (59{\%} versus 56.6{\%}, respectively; p = 0.536). Seventy-three percent of INR values for patients who attended group visits were within ±0.2 of the desired INR range compared with 71.9{\%} of those in the control group (p = 0.994). In addition, 79{\%} of group-visit patients were within the therapeutic range at their last clinic visit compared with 67{\%} of patients who attended individual appointments (p = 0.225). Group visits were preferred by 51{\%} (n = 38) of patients who completed the satisfaction survey. Of the 92 patients who declined group-visit participation, 36{\%} indicated that the time of day that group visits were offered was inconvenient. There were no thromboembolic or hemorrhagic events documented in either group during the study period. Conclusion. Group visits in a pharmacist-managed anticoagulation clinic may provide a safe and effective alternative to individual appointments.",
keywords = "Ambulatory care, Anticoagulants, International normalized ratio, Methodology, Patients, Pharmacists, Toxicity, Warfarin",
author = "Griffin, {Brooke L.} and Burkiewicz, {Jill S.} and Peppers, {Laura R.} and Warholak, {Terri L}",
year = "2009",
month = "7",
day = "1",
doi = "10.2146/ajhp080278",
language = "English (US)",
volume = "66",
pages = "1218--1223",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "13",

}

TY - JOUR

T1 - International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic

AU - Griffin, Brooke L.

AU - Burkiewicz, Jill S.

AU - Peppers, Laura R.

AU - Warholak, Terri L

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Purpose. The clinical effectiveness of a group-visit model versus individual point-of-care visits is compared by International Normalized Ratio (INR) monitoring in a pharmacist-managed anticoagulation clinic. Methods. This study was a prospective, randomized, repeated-measures, two-group, intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care ambulatory care setting. Patients were eligible for this study if they were taking warfarin therapy for at least 30 days, had a goal INR range, and provided consent. At a routine point-of-care visit, eligible patients were randomly invited to participate in group visits. The number of visits and INR values were documented prospectively for both groups during the 16-week study period. Results. Of the 45 patients who consented and enrolled in group visits, 28 patients participated for the 16-week study period. The control group included 108 patients seen by a pharmacist for individual anticoagulation appointments. No significant difference in the percentage of INR values within the therapeutic range was detected between patients in the group-visit model versus patients receiving individual visits (59% versus 56.6%, respectively; p = 0.536). Seventy-three percent of INR values for patients who attended group visits were within ±0.2 of the desired INR range compared with 71.9% of those in the control group (p = 0.994). In addition, 79% of group-visit patients were within the therapeutic range at their last clinic visit compared with 67% of patients who attended individual appointments (p = 0.225). Group visits were preferred by 51% (n = 38) of patients who completed the satisfaction survey. Of the 92 patients who declined group-visit participation, 36% indicated that the time of day that group visits were offered was inconvenient. There were no thromboembolic or hemorrhagic events documented in either group during the study period. Conclusion. Group visits in a pharmacist-managed anticoagulation clinic may provide a safe and effective alternative to individual appointments.

AB - Purpose. The clinical effectiveness of a group-visit model versus individual point-of-care visits is compared by International Normalized Ratio (INR) monitoring in a pharmacist-managed anticoagulation clinic. Methods. This study was a prospective, randomized, repeated-measures, two-group, intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care ambulatory care setting. Patients were eligible for this study if they were taking warfarin therapy for at least 30 days, had a goal INR range, and provided consent. At a routine point-of-care visit, eligible patients were randomly invited to participate in group visits. The number of visits and INR values were documented prospectively for both groups during the 16-week study period. Results. Of the 45 patients who consented and enrolled in group visits, 28 patients participated for the 16-week study period. The control group included 108 patients seen by a pharmacist for individual anticoagulation appointments. No significant difference in the percentage of INR values within the therapeutic range was detected between patients in the group-visit model versus patients receiving individual visits (59% versus 56.6%, respectively; p = 0.536). Seventy-three percent of INR values for patients who attended group visits were within ±0.2 of the desired INR range compared with 71.9% of those in the control group (p = 0.994). In addition, 79% of group-visit patients were within the therapeutic range at their last clinic visit compared with 67% of patients who attended individual appointments (p = 0.225). Group visits were preferred by 51% (n = 38) of patients who completed the satisfaction survey. Of the 92 patients who declined group-visit participation, 36% indicated that the time of day that group visits were offered was inconvenient. There were no thromboembolic or hemorrhagic events documented in either group during the study period. Conclusion. Group visits in a pharmacist-managed anticoagulation clinic may provide a safe and effective alternative to individual appointments.

KW - Ambulatory care

KW - Anticoagulants

KW - International normalized ratio

KW - Methodology

KW - Patients

KW - Pharmacists

KW - Toxicity

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=70349256427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349256427&partnerID=8YFLogxK

U2 - 10.2146/ajhp080278

DO - 10.2146/ajhp080278

M3 - Article

VL - 66

SP - 1218

EP - 1223

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 13

ER -